Clinical Trial Results:
            A Phase 2, open label, dose regimen ranging clinical study to  determine the safety and efficacy of INCB018424 in patients with  advanced polycythemia vera or essential thrombocythemia  refractory to hydroxyurea
    
|     Summary | |
|     EudraCT number | 2008-001382-28 | 
|     Trial protocol | IT | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    28 Jul 2022
                             | 
|     First version publication date | 
                                    28 Jul 2022
                             | 
|     Other versions | |
|     Summary report(s) | 2008-001382-28.INCB 18424-256.Results Summary | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
